What is Clinical Strategy & Services?
With a dedicated clinical strategy team, API is committed to advancing health research and delivering impactful outcomes through the development and execution of clinical programs and trials. We work collaboratively with industry partners, academic institutions, community researchers, and regulatory authorities to ensure the successful development and execution of clinical strategies that drive innovation and contribute to the advancement of healthcare.
Key Focus Areas:
- Clinical Program Development: We work with you on the development of Phase I to Phase IV clinical programs tailored to specific therapeutic areas, as well as feasibility & pilot studies and usability testing.
- Trial Design and Strategy: We support trial design and help you develop a roadmap to implement clinical trials & clinical health research studies that adhere to regulatory standards and best practices.
- Patient-Centric Approach: Our commitment to patient-centricity informs every aspect of our clinical strategies. We design with a focus on improving patient experiences and outcomes, fostering a human-centered approach to healthcare innovation.
Benefits of Clinical Strategy & Services
Partner with API’s Clinical Strategy & Services team to drive commercialization, ensure regulatory success, and make a lasting impact on the future of healthcare:
- Accelerated Development: We help you streamline your processes to accelerate the development timeline of clinical programs and trials.
- Medical Writing Support: Ensure clarity and compliance with our medical writing services. Our team will help you write clinical protocols, clinical study reports, investigators’ brochures, informed consent forms, and other regulatory documents to the highest quality and scientific standards.
- Risk Mitigation: Working with API can allow you to proactively identify and mitigate risks, ensuring safety and efficacy through all phases of clinical development.
- Regulatory Success: We’ll help you increase likelihood of regulatory success through strategic planning and compliance expertise across a variety of programs.
- Innovation and Adaptability: Our emphasis on innovative approaches and adaptive strategies helps you stay ahead in the rapidly evolving healthcare landscape.
- Enhanced Collaboration: Collaboration with our network of industry partners and academic institutions helps to enhance our collective impact on health research.
Clinical Strategy & Services Team
Launa Aspeslet
Board Chair
Read bioabout Launa AspesletLauna Aspeslet
Board Chair
Dr. Launa J. Aspeslet is COO of Hepion Pharmaceuticals, a biotechnology company with offices in Edmonton, AB, and New Jersey, USA working on a treatment for liver and other fibrotic diseases. Dr. Aspeslet has over 25 years experience in the pharmaceutical industry overseeing large operating budgets and dozens of multiple-phase clinical trials. Prior to Hepion, Dr. Aspeslet was the CEO of TRIO, a global clinical research organization headquartered in Edmonton that runs oncology trials around the globe, a biotechnology consultant working with early stage companies through their product development strategy, and COO for Isotechnika Pharma Inc., a former Edmonton biotechnology company. Launa is also currently on the Board of Directors for Edmonton Unlimited.
Julianna Weber
Director, Clinical & Regulatory Affairs
Bronsen Kwong
Product Manager Associate
Want assistance with Clinical Strategy & Services?
Contact us to discuss how our expertise can benefit your specific clinical development needs.
"*" indicates required fields
Related Services
Regulatory Strategy & Compliance
From strategy & planning to preparing regulatory filings, API provides guidance…
Clinical Pharmacology
Combining scientific expertise, regulatory knowledge, and cutting-edge technology, API offers strategic support to…
Biostatistical Analysis
API offers strategic support through robust biostatistical analysis to extract meaningful insights and…